NARI

Inari Medical Inc

NARI.US inarimedical.com
Price N/A
USD · NASDAQ
52-week range
0.00
0.00
Market Cap
4.68B
P/E Ratio
0.00
Forward P/E
526.32
Book Value
7.44
Div. Yield
N/A
% Institutions
95.56%
% Insiders
9.00%

1 Year

+37.6%

3 Year

+3.5%

10 Year

+88.1%
Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.

Company Information

Company Name
Inari Medical Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US45332Y1091
CIK: 0001531048
CUSIP: 45332Y109
Currency: USD
Full Time Employees: 1,300
Phone: 877 923 4747
Fiscal Year End: December
IPO Date: May 22, 2020
Description:

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.

Address:

6001 Oak Canyon, Irvine, CA, United States, 92618

People

Directors & Officers

Name Title Year Born
Mr. Kevin Strange Chief Financial Officer NA
Mr. Paul A. Koehn Senior Vice President of Operations 1963
Ms. Karen Silva Vice President of Finance & Accounting NA
Mr. Hussain Rangwala Chief Technology Officer NA
Mr. Neil Bhalodkar Vice President of Investor Relations NA
Ms. Shannon Trevino General Counsel & Corporate Secretary NA
Mr. Eric Khairy Senior Vice President of Marketing NA
Ms. Tara Dunn Senior VP & GM of LimFlow NA
Dr. Shon Chakrabarti M.D., M.P.H. Chief Medical Officer of LimFlow NA
Mr. Tim A. Benner Chief Commercial Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 06, 2025 William Hoffman N/A Sale 200.00K $60.47 $12.09M
Dec 20, 2024 Andrew Hykes N/A Sale 3.00K $55.29 $165.87K
Dec 16, 2024 William Hoffman N/A Sale 60.00K $55.66 $3.34M
Nov 18, 2024 William Hoffman N/A Sale 60.00K $51.16 $3.07M
Oct 29, 2024 Andrew Hykes N/A Sale 3.00K $50.00 $150.00K
Oct 29, 2024 William Hoffman N/A Sale 40.00K $50.05 $2.00M
Oct 16, 2024 William Hoffman N/A Sale 40.00K $45.02 $1.80M
Sep 16, 2024 William Hoffman N/A Sale 40.00K $45.83 $1.83M
Sep 12, 2024 Mitch C Hill N/A Sale 3.00K $45.13 $135.39K
Aug 12, 2024 Mitch C Hill N/A Sale 5.00K $47.99 $239.95K
Jul 22, 2024 Andrew Hykes N/A Sale 3.00K $55.23 $165.69K
Jul 16, 2024 William Hoffman N/A Sale 60.00K $56.74 $3.40M
Jul 15, 2024 Thomas Tu N/A Sale 16.52K $55.09 $910.09K
Jul 12, 2024 Mitch C Hill N/A Sale 5.00K $53.95 $269.75K
Jul 01, 2024 Andrew Hykes N/A Sale 3.00K $50.08 $150.24K
Jul 01, 2024 William Hoffman N/A Sale 20.00K $50.15 $1.00M
Jun 21, 2024 Rebecca Chambers N/A Sale 260.00 $45.99 $11.96K
Jun 12, 2024 Mitch C Hill N/A Sale 5.00K $47.60 $238.00K
May 28, 2024 Andrew Hykes N/A Sale 3.00K $50.00 $150.00K
May 28, 2024 William Hoffman N/A Sale 60.00K $50.13 $3.01M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 8.39M Dec 31, 2024 14.33% $0.01 0.78%
Vanguard Group Inc 5.63M Dec 31, 2024 9.61% $0.01 0.55%
Mackenzie Investments 2.73M Dec 31, 2024 4.66% $0.09 219.43%
Morgan Stanley - Brokerage Accounts 2.15M Dec 31, 2024 3.67% $0.01 85.21%
State Street Corp 2.08M Dec 31, 2024 3.56% $0.00 2.34%
Brown Advisory Holdings Inc 1.81M Dec 31, 2024 3.09% $0.12 -0.80%
Jennison Associates LLC 1.76M Dec 31, 2024 3.01% $0.05 11.84%
Armistice Capital, LLC 1.57M Dec 31, 2024 2.67% $1.09 -14.07%
BAMCO Inc 1.31M Dec 31, 2024 2.24% $0.17 30.45%
UBS Asset Mgmt Americas Inc 1.22M Dec 31, 2024 2.09% $0.01 -3.69%
Geode Capital Management, LLC 1.21M Dec 31, 2024 2.07% $0.00 -0.04%
American Century Companies Inc 1.07M Dec 31, 2024 1.82% $0.03 9.10%
Millennium Management LLC 950.51K Dec 31, 2024 1.62% $0.02 -0.90%
JPMorgan Chase & Co 896.79K Dec 31, 2024 1.53% $0.00 -60.09%
Fuller & Thaler Asset Management Inc 870.63K Dec 31, 2024 1.49% $0.17 13.29%
Manufacturers Life Insurance Co 842.56K Dec 31, 2024 1.44% $0.04 5.97%
Woodline Partners LP 712.91K Dec 31, 2024 1.22% $0.25 0.00%
Dimensional Fund Advisors, Inc. 701.44K Dec 31, 2024 1.20% $0.01 6.61%
Northern Trust Corp 693.09K Dec 31, 2024 1.18% $0.01 7.42%
Eventide Asset Management, LLC 619.65K Dec 31, 2024 1.06% $0.58 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard US Total Market Shares ETF 1.56M 2.66% ▲ 0.09% Sep 30, 2024
2 American Century U.S. Small Cap Growth 834.36K 1.42% ▼ 1.52% Dec 31, 2024
3 American Century Small Cap Growth Inv 834.36K 1.42% ▼ 1.52% Dec 31, 2024
4 Eventide Healthcare & Life Sciences I 619.65K 1.06% ▲ 0.00% Dec 31, 2024
5 FullerThaler Behavioral Small-Cap Growth 584.11K 1.00% ▲ 4.07% Dec 31, 2024
6 Fidelity Small Cap Index 522.02K 0.89% ▼ 1.84% Jan 31, 2025
7 Baron Opportunity Retail 256.00K 0.44% ▲ 0.00% Dec 31, 2024
8 JNL Multi-Manager Small Cap Growth A 205.02K 0.35% ▲ 24.24% Dec 31, 2024
9 Franklin US Small Cap Growth Equity 182.82K 0.31% ▲ 0.00% Dec 31, 2024
10 Voya Mid Cap Growth 171.21K 0.29% ▲ 19.89% Dec 31, 2024

Financial Highlights

Market Cap: $4.68B
EBITDA: $-26.13M
Book Value: $7.44
Earnings/Share: $-1.35
Profit Margin: -13.68%
Operating Margin: -4.34%
ROA (TTM): -3.21%
ROE (TTM): -17.72%
Revenue (TTM): $574.50M
Revenue/Share (TTM): $9.90
Earnings Growth (YOY): -83.90%
Revenue Growth (YOY): 21.40%

Valuation Metrics

Enterprise Value: $4.60B
Trailing P/E: 0.00
Forward P/E: 526.32

Shares Statistics

Shares Outstanding: 58.56M
Shares Float: 53.34M
% Insiders: 9.00%
% Institutions: 95.56%
Short % Float: 5.36%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$493.63M
Cost of Goods Sold
adjust
$-59.07M
Gross Profit
subtotal
$434.56M
SG&A
adjust
$-349.46M
R&D
adjust
$-87.53M
Other Operating Expense
adjust
$-11.60M
Operating Income
subtotal
$-14.03M
Other / Non-Operating Items
adjust
$12.40M
Net Income
subtotal
$-1.64M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NARI.US!